Laurie Haws is SOT Vice President-Elect
ToxStrategies congratulates our President and co-founder Dr. Laurie Haws on being elected Vice President-Elect of the Society of Toxicology (SOT)! Dr. Haws and… read more
Latest News
Poster for ACT discusses direct-to-brain pharmaceutical administration
ToxStrategies/21CT scientists are among the authors of a poster for the Annual Meeting of the American College of Toxicology, to be held virtually… read more
Workshop suggests journal editors can influence the quality of published systematic reviews
With the increasing prevalence of systematic reviews in toxicology and environmental research, a team of prominent scientists in the field convened a workshop… read more
Cross-discipline team publishes on Cr(VI) in air
A team of 21CT and EpidStrategies scientists are authors on a manuscript being published in Regulatory Toxicology and Pharmacology. The study examines current… read more
Nature publishes article on predicting adverse effects to new drugs
ToxStrategies Information Specialist Ms. Seneca Fitch is among a group of scientists from the regulatory community, academia, the pharmaceutical industry, and consulting who have published an… read more
New studies published on formaldehyde health effects
ToxStrategies scientists Dr. Chad Thompson, Dr. Allison Franzen, and Ms. Seneca Fitch and their colleagues have published a pair of papers in a special issue of Critical Reviews in… read more
ToxStrategies scientists assess carcinogenicity of non-nutritive sweetener, acesulfame K
A recently published article by ToxStrategies scientists presents the systematic identification, appraisal, and integration of mechanistic data in an assessment of the potential… read more
Recent publication comparing the Threshold of Toxicological Concern (TTC) values and oral reference dose (RfD) values
ToxStrategies’ scientists have proposed potential expansions of the use cases for the threshold of toxicological concern (TTC) in human health risk assessment applications…. read more